Nose zap might stop migraines before they start
NCT ID NCT07279623
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a small device placed inside the nose that delivers gentle stimulation to prevent migraines. 110 adults with migraines will use the device at home every other day for six weeks. Researchers will track how many migraine days they have compared to a group that starts treatment later. The goal is to see if this drug-free approach is safe and effective for migraine prevention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
INMEST-mottagningen Odenplan
RECRUITINGStockholm, 11327, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?